Dr. Devnandini Rastogi, MD

NPI: 1710903935
Total Payments
$230,240
2024 Payments
$75,702
Companies
5
Transactions
327

Payment Breakdown by Category

Other$197,645 (85.8%)
Travel$16,855 (7.3%)
Consulting$8,847 (3.8%)
Food & Beverage$6,878 (3.0%)
Education$14.94 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $197,645 104 85.8%
Travel and Lodging $16,855 98 7.3%
Consulting Fee $8,847 4 3.8%
Food and Beverage $6,878 117 3.0%
Education $14.94 4 0.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $91,618 127 $0 (2024)
Otsuka America Pharmaceutical, Inc. $85,243 133 $0 (2024)
Alkermes, Inc. $29,520 32 $0 (2021)
E.R. Squibb & Sons, L.L.C. $23,450 23 $0 (2024)
Otsuka Pharmaceutical Development & Commercialization, Inc. $409.35 12 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $75,702 91 Otsuka America Pharmaceutical, Inc. ($26,414)
2023 $40,892 54 Otsuka America Pharmaceutical, Inc. ($21,453)
2022 $24,501 32 Janssen Pharmaceuticals, Inc ($14,826)
2021 $16,728 19 Janssen Pharmaceuticals, Inc ($11,756)
2020 $14,927 33 Otsuka America Pharmaceutical, Inc. ($5,930)
2019 $34,005 49 Alkermes, Inc. ($21,714)
2018 $13,075 25 Otsuka America Pharmaceutical, Inc. ($9,346)
2017 $10,410 24 Otsuka America Pharmaceutical, Inc. ($6,070)

All Payment Transactions

327 individual payment records from CMS Open Payments — Page 1 of 14

Date Company Product Nature Form Amount Type
12/11/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,140.00 General
Category: Psychiatry/Psychology
12/10/2024 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $141.92 General
12/10/2024 E.R. Squibb & Sons, L.L.C. Travel and Lodging Cash or cash equivalent $92.80 General
12/10/2024 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $49.12 General
12/05/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,300.00 General
Category: Psychiatry/Psychology
12/05/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Travel and Lodging Cash or cash equivalent $12.06 General
Category: Psychiatry/Psychology
12/04/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII Travel and Lodging Cash or cash equivalent $33.50 General
Category: PSYCHIATRY
11/28/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,808.00 General
Category: PSYCHIATRY
11/25/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,140.00 General
Category: Psychiatry/Psychology
11/14/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Travel and Lodging Cash or cash equivalent $1,035.32 General
Category: Psychiatry/Psychology
11/14/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $72.27 General
Category: Psychiatry/Psychology
11/12/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,750.00 General
Category: Neuroscience
11/08/2024 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $6,440.00 General
11/08/2024 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $460.00 General
11/07/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $121.83 General
Category: Psychiatry/Psychology
10/31/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Travel and Lodging Cash or cash equivalent $115.50 General
Category: Neuroscience
10/31/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage Cash or cash equivalent $40.09 General
Category: Neuroscience
10/31/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage Cash or cash equivalent $12.54 General
Category: Neuroscience
10/31/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage Cash or cash equivalent $4.69 General
Category: Neuroscience
10/29/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Travel and Lodging Cash or cash equivalent $1,194.04 General
Category: Psychiatry/Psychology
10/29/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $124.99 General
Category: Psychiatry/Psychology
10/19/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $59.41 General
Category: Neuroscience
10/19/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $58.92 General
Category: Neuroscience
10/19/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $40.00 General
Category: Neuroscience
10/18/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Travel and Lodging In-kind items and services $406.19 General
Category: Neuroscience

About Dr. Devnandini Rastogi, MD

Dr. Devnandini Rastogi, MD is a Psychiatry healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710903935.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Devnandini Rastogi, MD has received a total of $230,240 in payments from pharmaceutical and medical device companies, with $75,702 received in 2024. These payments were reported across 327 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($197,645).

Practice Information

  • Specialty Psychiatry
  • Location Saint Louis, MO
  • Active Since 07/14/2006
  • Last Updated 07/20/2011
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1710903935

Products in Payments

  • INVEGA SUSTENNA (Drug) $84,632
  • ABILIFY MAINTENA (Drug) $80,969
  • ARISTADA (Drug) $29,520
  • COBENFY (Drug) $13,141
  • INVEGA TRINZA (Drug) $6,386
  • ABILIFY ASIMTUFII (Drug) $3,382
  • REXULTI (Drug) $1,103
  • INVEGA (Drug) $502.84
  • ABILIFY MYCITE (Drug) $22.70

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Saint Louis